Nuveen’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Nuveen’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,360	Closed	-$149K	–	3455
2024 Q1	$149K	Hold	30,360	–	–	﹤0.01%	3221
2023 Q4	$111K	Hold	30,360	–	–	﹤0.01%	3276
2023 Q3	$67.4K	Hold	30,360	–	–	﹤0.01%	3149
2023 Q2	$103K	Hold	30,360	–	–	﹤0.01%	3163
2023 Q1	$121K	Hold	30,360	–	–	﹤0.01%	3041
2022 Q4	$165K	Hold	30,360	–	–	﹤0.01%	3067
2022 Q3	$153K	Hold	30,360	–	–	﹤0.01%	3135
2022 Q2	$116K	Buy	+30,360	New	+$194K	﹤0.01%	3187

Nuveen's TGAN Position: Q2 2024 in Review

Nuveen sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 30,360 shares — an estimated $149K sold.

Nuveen first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $165K in Q4 2022. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Nuveen reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Nuveen sold 30,360 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $149K.
Nuveen first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Nuveen's Transphorm, Inc. Common Stock position peaked at $165K in Q4 2022.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.